Brief: Mei Pharma Issues Statement Regarding Anson And Cable Car's Opportunistic Actions
28/09/2023 23:08
Sept 28 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA ISSUES STATEMENT REGARDING ANSON AND CABLE
CAR’S
OPPORTUNISTIC ACTIONS
* MEI PHARMA INC- BOARD OF DIRECTORS AND MANAGEMENT TEAM ARE
FOCUSED ON ADVANCING OUR TWO PROGRAMS, VORUCICLIB AND ME-344
* MEI PHARMA INC- MEI BOARD HAVE EVALUATED ANSON AND CABLE
CAR'S
LATEST REQUEST TO SET A NEW RECORD DATE AND DETERMINED THERE WAS
NO BASIS FOR DOING SO
* MEI PHARMA INC- ON SEPT 13 ANSON AND CABLE CAR BY LETTER
UNILATERALLY ENDED DISCUSSIONS AND TERMINATED AGREEMENT WITH CO
ON CONDUCT OF DISCUSSIONS
* MEI PHARMA INC- RECORD DATE THAT WAS SET AT EXPRESS
REQUEST OF
ANSON AND CABLE CAR FOR THEIR CONSENT SOLICITATION REMAINS
AUGUST 11, 2023
Source text for Eikon: ID:nBw9NHVRYa
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations